Research & R&D roadmap

Five uncertainties. One responsible path forward.

Our 12-month portfolio is structured to test whether Aletheia can create trustworthy early-warning value without sacrificing usability, privacy, or calm.

Research status

The metrics below are planning targets for controlled research—not proven clinical performance, product claims, or evidence of regulatory clearance.

P1
Foundation

Signal & Digital Biomarker Engine

Can low-burden behavioral signals reveal meaningful longitudinal change?

12-month planning target≥85% usable data≥80% weekly adherence
P2
Foundation

Alert Classification Engine

Can the system distinguish a credible anomaly from noise while protecting sensitivity?

Research objectiveControl false discoveryBaseline, test, and calibrate
P3
Core differentiator

Explainable Cognitive Risk Engine

Can individualized models identify change while controlling false alerts and showing their reasoning?

12-month planning target≥0.80 sensitivityat ≤10% false-alert rate
P4
Adoption

Human-Centered Awareness Experience

Can people understand and act on insights without unnecessary alarm or fatigue?

12-month planning target≥85% comprehension≥60% recommended-action uptake
P5
Risk reduction

Privacy, Governance & Validation

Can the concept be governed, audited, and responsibly prepared for future healthcare research?

12-month planning targetAuditable consentNo critical privacy findings

Technology roadmap

Stage evidence before ambition.

Each horizon depends on validation and governance from the horizon before it.

2026

Foundational awareness

Signal research, longitudinal data foundations, awareness prototypes, and privacy governance.

2027–2028

Intelligent monitoring

Digital biomarkers, calibrated risk research, personalized explanations, and controlled pilots.

2029–2031

Predictive research

Subject to evidence: forecasting research, clinical workflow studies, and responsible decision support.

2032+

Precision ecosystem vision

Long-term possibilities such as adaptive pathways and integrated systems—only if validated and appropriate.

Portfolio figure of merit

Actionable Awareness Value

A team-developed decision measure to balance possible early-warning value with false alerts and user burden. It is not a clinical metric.

IncreaseLead time · sensitivity · engagement
ControlFalse alerts · user burden

The goal is disciplined trade-offs—not accuracy at any cost.